Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Cygnus Medicare sells...

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Farhat NasimWritten by Farhat Nasim Published On 2019-11-25T12:00:06+05:30  |  Updated On 14 Aug 2021 2:36 PM IST

    The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the secondary investment which provides an exit to angel investors and a partial exit to existing institutional investors, Amar Ujala said.


    New Delhi: Leading media firm Amar Ujala Ltd has acquired a majority stake in Cygnus Medicare, which operates a chain of super speciality hospitals, for around Rs 130 crore as part of its expansion plans in the healthcare segment.


    Cygnus Medicare currently has more than 1,000 beds across its 10 super speciality hospitals in Delhi and Haryana.


    "We have concluded a deal of around Rs 130 crore with Cygnus Medicare to take over their 10 hospitals and added our two hospitals in the overall portfolio," Amar Ujala Ltd Director Probal Ghosal told PTI.


    The company has acquired a majority share in Cygnus Medicare with management control, he added.


    On raising of funds for the acquisition, Ghosal said, "It is through internal accruals."


    The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the secondary investment which provides an exit to angel investors and a partial exit to existing institutional investors, Amar Ujala said.


    In the merged entity, Amar Ujala through its healthcare arm will hold a significant stake along with management control and balance will be held by Eight Roads Ventures, Somerset Indus, Evolvence India and previous promoters - Dr Dinesh Batra and Dr Shuchin Bajaj, respectively, it added.


    "As part of the deal, Batra and Bajaj will be on the board of the merged entity and continue in their previous roles whereas I will be the chairman," Ghosal said.


    Going forward, "we plan to have a total of 20 hospitals in three years. Idea is to create more access points and make it more inclusive with hub and spoke model. We also plan to create multiple access points at the primary care level", he added.


    On the business model the company follows, Ghosal said: "We follow the asset-light model. We take the hospitals on long term rent and sometimes on the revenue sharing model."


    The company is also looking to provide inclusive primary and preventive healthcare access through innovative digital devices and solutions, he added.


    The company is committed to creat healthcare facilities in Haryana, Uttar Pradesh, Uttarakhand, Himachal Pradesh and Jammu & Kashmir, Ghosal said.


    "We felt the need of creating infrastructure and multiple access points with high-quality healthcare delivery systems and accordingly we ventured into this space to work for the underserved tier II and tier III people in northern India," he added.


    Stating that the deal would greatly improve access to quality tertiary healthcare in tier II and III towns, Cygnus Medicare promoter Dinesh Batra said: "The asset-light model being pursued, by both Amar Ujala and us, is highly scalable and replicable in the Indian context."


    The prime focus is to attract highly skilled specialists and super specialists to smaller towns, he added.


    Also Read: Cognizant completes acquisition of Bolder Healthcare Solutions

    Acquisitionamar ujalaBajajcygnus medicarecygnus stakeEight Roads VenturesEvolvence IndiaHealthcarehealthcare expansionhospitalsmergerprobal ghosalSharesSomerset Indus
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok